Published in Cell Mol Neurobiol on September 01, 1987
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Metabolism of monoamine oxidase inhibitors. Cell Mol Neurobiol (1999) 0.87
"Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment. J Psychiatry Neurosci (1991) 0.78
Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77
Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. J Psychiatry Neurosci (2002) 0.75
Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cell Mol Neurobiol (2004) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorg Med Chem (1999) 1.54
Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci (1990) 1.46
A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem (1997) 1.29
Azole substituted oligonucleotides promote antiparallel triplex formation at non-homopurine duplex targets. Nucleic Acids Res (1995) 1.09
Gelastic, quiritarian, and cursive epilepsy. A clinicopathological appraisal. J Neurol Neurosurg Psychiatry (1976) 1.09
In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother (1999) 1.07
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev (1999) 1.04
Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) (1998) 1.04
Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells. Neuropharmacology (2000) 1.03
Anti-inflammatory activity of curcumin analogues. Indian J Med Res (1982) 1.02
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology (2000) 0.99
In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. J Neurochem (1989) 0.98
Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97
An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl) (1998) 0.97
Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci (2008) 0.96
A rapid and reliable solid-phase extraction--LC/MS/MS assay for the determination of two novel human leukocyte elastase inhibitors, SYN-1390 and SYN-1396, in rat plasma. J Pharm Biomed Anal (1999) 0.96
Triplex formation at the rat neu gene utilizing imidazole and 2'-deoxy-6-thioguanosine base substitutions. Biochemistry (1995) 0.96
Beta-lactamase inhibitors: agents to overcome bacterial resistance. Curr Med Chem (1998) 0.96
Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology (1991) 0.95
The subcellular distribution of beta-phenylethylamine, p-tyramine and tryptamine in rat brain. J Neurochem (1975) 0.94
Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol (1999) 0.94
Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Res (1986) 0.94
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.94
Novel sample preparation method facilitating identification of urinary drug metabolites by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.94
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94
An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand (2010) 0.93
Chirality and drugs used in psychiatry: nice to know or need to know? Cell Mol Neurobiol (1999) 0.92
Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav (1994) 0.92
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 0.90
Binding of T and T analogs to CG base pairs in antiparallel triplexes. Nucleic Acids Res (1994) 0.88
Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) (2001) 0.87
A gas-liquid chromatographic method for the estimation of 2-phenylethylamine in rat brain tissue. Biochem Pharmacol (1977) 0.87
p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav Brain Res (1995) 0.87
Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology (1990) 0.87
Acute tyrosine depletion and alcohol ingestion in healthy women. Alcohol Clin Exp Res (2000) 0.86
Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones. J Antibiot (Tokyo) (1994) 0.86
Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Biochem Pharmacol (2000) 0.86
Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo. J Neurochem (1990) 0.86
Tourette syndrome and neuropsychological performance. Acta Psychiatr Scand (1991) 0.85
Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr (1992) 0.85
Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog Brain Res (1995) 0.85
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J Neurochem (1994) 0.85
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85
Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab Dispos (1998) 0.85
The future of antidepressants. Biomed Pharmacother (1996) 0.85
Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J Psychopharmacol (1998) 0.85
Activity and metabolism-related Ca2+ and mitochondrial dynamics in co-cultured human fetal cortical neurons and astrocytes. Neuroscience (2013) 0.84
Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res (1990) 0.84
Neurobiology of panic disorder. J Psychosom Res (1998) 0.84
Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (2000) 0.84
N-methyl-D-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology (1991) 0.83
Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis. Neurogastroenterol Motil (2008) 0.83
Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C. Neurogastroenterol Motil (2008) 0.83
Dynamics of Deinococcus radiodurans under controlled growth conditions. Biophys J (2006) 0.83
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83
Does mebendazole inhibit lactation? N Z Med J (1983) 0.83
Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives. Antimicrob Agents Chemother (2000) 0.83
Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.83
Persistent proatlantal artery with carotid-vertebral anastomosis. Case report. J Neurosurg (1975) 0.82
Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. Chirality (1989) 0.82
The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) (1996) 0.82
Interactions of iprindole with fenfluramine metabolism in rat brain and liver. J Psychiatry Neurosci (1991) 0.82
Anticonvulsant activities of 4-bromobenzaldehyde semicarbazone. Epilepsia (1994) 0.82
The metabolism of trimipramine in the rat. Biomed Environ Mass Spectrom (1990) 0.82
Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J Neurochem (1997) 0.82
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo. Neuropharmacology (1991) 0.81
High-performance liquid chromatographic analysis of new triazole antifungal agent SYN-2869 and its derivatives in plasma. J Pharm Biomed Anal (1999) 0.81
Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav (2000) 0.81
Structural characterization of the urinary metabolites of iprindole in rat. Xenobiotica (1991) 0.81
The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci (1998) 0.81
High-performance liquid chromatographic assay for the determination of novel triazole antifungal agents in tissue. Application to tissue distribution studies. Biomed Chromatogr (2000) 0.81
Application of capillary electrophoresis with laser-induced fluorescence detection to the determination of biogenic amines and amino acids in brain microdialysate and homogenate samples. J Chromatogr A (2001) 0.81
Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur Neuropsychopharmacol (1996) 0.81
Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies. J Mass Spectrom (1999) 0.81
Inhibition of β-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons. Neuroscience (2011) 0.81
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol (1995) 0.81
Depression and memory in major depressive disorder. J Neuropsychiatry Clin Neurosci (1991) 0.80
Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles. Cancer Lett (1994) 0.80
Preparations of liposomal fluconazole and their in vitro antifungal activity. J Microencapsul (1993) 0.80
Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse. Br J Pharmacol (1999) 0.80
SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J Pharmacol Exp Ther (2001) 0.80
Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology (Berl) (1999) 0.79
4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1999) 0.79
Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain. Cell Mol Neurobiol (2001) 0.79
Congenital meningioma with subdural hygroma and porencephaly (a case report). Neurol India (1975) 0.79
Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol (1986) 0.79
Plasma amino acids in attention deficit disorder. Psychiatry Res (1990) 0.79
In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. J Med Chem (1996) 0.79
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J Neural Transm (Vienna) (1998) 0.79
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. J Pharm Sci (1992) 0.79
Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Psychopharmacology (Berl) (1998) 0.79
Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.79
Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. J Chromatogr B Biomed Sci Appl (1997) 0.79
Sensitive high-performance liquid chromatographic assay for norfloxacin utilizing fluorescence detection. J Chromatogr B Biomed Appl (1995) 0.79